Patent · US Active

Gastroduodenal artery neuromodulation

US9089541B2 · kind B2 · utility

22Cited by

89References

20Claims

0Family size

Assignee

Metavention, Inc. · US

Inventors

Bobak Robert Azamian · San Joaquin Hills, US
Jonathan Allen Coe · Menlo Park, US
Scott Bradley Vafai · Boston, US

Key dates

Filing date	Nov 8, 2013
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Jan 25, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N7/022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid deliver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.